Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions in China and internationally. The company offers various products, including patient monitoring, ultrasound, radiology, AED, defibrillation system, anesthesia, CLIA, chemistry, hematology, ventilators, electrocardiograph, endoscope camera system, operating tables, surgical lights, medical supply units, acces… Read more
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (300760) - Total Liabilities
Latest total liabilities as of September 2025: CN¥15.02 Billion CNY
Based on the latest financial reports, Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (300760) has total liabilities worth CN¥15.02 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A - Total Liabilities Trend (2014–2024)
This chart illustrates how Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A Competitors by Total Liabilities
The table below lists competitors of Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Symrise AG
PINK:SYIEF
|
USA | $3.99 Billion |
|
BSE Limited
NSE:BSE
|
India | ₹57.74 Billion |
|
Federal Home Loan Mortgage Corp Pref Perpetual
OTCQB:FMCCT
|
USA | $3.43 Trillion |
|
China Coal Energy Co Ltd
SHG:601898
|
China | CN¥168.06 Billion |
|
Iflytek Co Ltd
SHE:002230
|
China | CN¥24.42 Billion |
|
Informa plc
PINK:IFPJF
|
USA | $6.46 Billion |
|
Alibaba Health Information Technology Limited
PINK:ALBBY
|
USA | $5.70 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.54 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (2014–2024)
The table below shows the annual total liabilities of Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥15.89 Billion | +8.85% |
| 2023-12-31 | CN¥14.59 Billion | -1.03% |
| 2022-12-31 | CN¥14.75 Billion | +32.43% |
| 2021-12-31 | CN¥11.13 Billion | +11.17% |
| 2020-12-31 | CN¥10.02 Billion | +42.74% |
| 2019-12-31 | CN¥7.02 Billion | +8.81% |
| 2018-12-31 | CN¥6.45 Billion | -17.15% |
| 2017-12-31 | CN¥7.78 Billion | -7.03% |
| 2016-12-31 | CN¥8.37 Billion | +43.75% |
| 2015-12-31 | CN¥5.83 Billion | +18.41% |
| 2014-12-31 | CN¥4.92 Billion | -- |